Skip to main content
. 2023 Jun 12;24(12):10033. doi: 10.3390/ijms241210033

Table 4.

The selected potential molecular drugs based on their regulatory ability, toxicity, sensitivity, and their binding of drug targets for the therapeutic treatment of psoriasis.

Target FOXO1 NF-kB STAT3 CEBPB ERK1/2 Toxicity
(LC50)
Sensitivity
(PRISM)
Drug
Betulinic acid 6.712 −0.103441
Butein 5.776 −0.054450
naringin 6.921 0.132488
Chemical structure of multiple molecules drug
Betulinic acid Butein naringin
graphic file with name ijms-24-10033-i001.jpg graphic file with name ijms-24-10033-i002.jpg graphic file with name ijms-24-10033-i003.jpg